Announcement

Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland

Abbott

Clinical Trial

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

Abbott

Abbott Receives FDA Emergency Use Authorization for its COVID-19 Blood Test

Abbott

FDA Authorization

Abbot Receives FDA Authorization for COVID-19 Antibody Blood Test System

Abbott

Insulin Delivery

Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care

Abbott

Prequalification Approval

Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test

Abbott

FDA

FDA Approves World's First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect)

Abbott

Partnership

Abbott and "Malaria No More" Work Together to End Malaria in Odisha, India

Abbott

Presentation

Abbott to Present at J.P. Morgan Healthcare Conference

Abbott

New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant

Abbott

Influenza

Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Abbott

FDA Approval

Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant

Abbott

Clinical Data

One-Year Results from Real-World Study Showed Abbott's Portico™ Transcatheter Aortic Valve Safely and Successfully Reduced Severe Aortic Stenosis

Abbott

FDA Approval

Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves

Abbott

Innovation

Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation

Abbott

Clinical Data

New Long-Term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's HeartMate 3 Heart Pump

Abbott

Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon

Abbott